对ABA受体激动剂的结构洞察力揭示了优化和设计广谱ABA信号激活器的关键特征
Mar Bono1, Cristian Mayordomo1, Alberto Coego1
1Instituto de Biología Molecular y Celular de Plantas (IBMCP), Consejo Superior de Investigaciones Científicas - Universidad Politécnica de Valencia, 46022 Valencia, Spain.
Molecular plant
|July 27, 2025
概括
一种新的植物激素激动剂iCB有效地激活了酸 (ABA) 受体,提高了干旱耐受性和作物产量. 这一发现为农业管理水资源短缺提供了一种新的战略.
科学领域:
- 植物生物学 植物生物学
- 生物化学 生物化学
- 农业科学 农业科学
背景情况:
- 农作物产量面临越来越多的水资源短缺和气候变化的威胁.
- 针对激素受体的农业化学品可以调节植物的用水量和应激反应.
- 激活PYRABACTIN RESISTANCE 1 (PYR1) /PYR1-LIKE (PYL) /ABA受体的调节成分 (RCAR) 家族对于管理水资源短缺至关重要.
研究的目的:
- 为PYR/PYL/RCAR酸受体家族开发和结构性地表征一种新型的激动剂,iCB.
- 调查iCB在不同ABA受体亚家族和植物物种中的激活概况和选择性.
- 评估iCB在改善植物干旱耐受性和生理性能方面的有效性.
主要方法:
- 结构导向的设计和脚手架的合并,以创建iCB的激进分子.
- 用X射线结晶学分析与ABA受体配合的奥帕巴克和ICB三元复合体.
- 在体外测试以确定受体激活度 (nM) 和亲缘关系.
- 对iCB对植物干旱耐受性,光合作用和基因表达的影响的生理评估.
主要成果:
- 新型激素iCB激活PYR/PYL/RCAR受体亚家族II和III在低纳米度和亚家族I在更高纳米度.
- 结构分析揭示了选择性决定的残留物,解释了受体亚家族和植物物种之间的差异性激素敏感性.
- 与opabactin相比,iCB显示了PYL8类受体的更广泛激活,包括那些残留量较大的受体.
- iCB治疗保护了番茄植物免受干旱的影响,改善了光合作用,并诱导了类似ABA的转录反应.
结论:
- iCB是ABA受体的强效和广泛作用的激动剂,为干旱压力提供了增强的保护.
- 对iCB-受体相互作用的结构洞察力有助于设计优化的激动剂,以改善作物中缺水管理.
- 由于iCB能够激活多种ABA受体并改善植物生理学,这为农业应用提供了有前途的途径.
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.3K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.3K
Drug-Receptor Interaction: Agonist
2.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.8K
The Two-State Receptor Model
2.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.4K
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
1.0K
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
1.0K
Drug-Receptor Interactions
6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.2K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.2K


